- 501. Rb86 isotope
- [ ] (UMLS (CSP) C0303558) =Indicator, Reagent, or Diagnostic Aid; Element, Ion, or Isotope ;
| - 551. Reagent
- [A chemical that has general laboratory application and that is not labeled or otherwise intended for a specific application. General purpose reagents include cytological preservatives, decalcifying reagents, fixatives and adhesives, tissue processing reagents, isotonic solutions, and pH buffers. ( NCI )] (UMLS (NCI) C0034760) =Indicator, Reagent, or Diagnostic Aid
|
- 502. RBBB
- [An impairment of transmission of the cardiac electrical impulse along the fibers of the right bundle branch. A " complete RBBB pattern" (with QRS duration > 0.11s) does not necessarily reflect the existence of a total conduction block in the right branch. This pattern only indicates that the entire or major parts of both ventricles are activated by the impulse emerging from the left branch. Thus, a significant degree of conduction delay ("high-grade" or "incomplete RBBB) can produce a similar pattern. ( NCI )] (UMLS (NCI) C0085615) =Disease or Syndrome
| - 552. Reagent Calibrator
- (UMLS (HL7) C1550148) =Indicator, Reagent, or Diagnostic Aid =Substance type;
|
- 503. RBBP9
- [This gene is involved in the regulation of cellular proliferation and differentiation. ( NCI )] (UMLS (NCI) C1419294) RBBP9 Gene;
Retinoblastoma Binding Protein 9 Gene =Gene or Genome | - 553. reagent standard
- [ ] (UMLS (CSP) C1328942) =Intellectual Product ;
|
- 504. RBC agglutination
- [Agglutination, RBC ( HL7V3.0 )] (UMLS (HL7) C1551409) =Laboratory Procedure =ObservationMethod;
| - 554. reagent standardization
- [ ] (UMLS (CSP) C1328943) =Intellectual Product ;
|
- 505. RBE
- [ratio of radiation dosages required to produce identical change based on a formula comparing other types of radiation with that of gamma or roentgen rays. ( CSP )] (UMLS (CSP) C0035023) =Quantitative Concept ;
=radiation dosage;
| - 555. reagent testing
- [ ] (UMLS (CSP) C1328944) =Research Activity ;
|
- 506. RBL2
- [This gene is involved in transcriptional regulation and cellular proliferation. ( NCI )] (UMLS (NCI) C1335602) RBL2 Gene;
Retinoblastoma-Like 2 (p130) Gene;
=Gene or Genome ;
| - 556. reagent/indicator
- [substance employed to produce a chemical reaction so as to detect, measure, or produce other substances. ( CSP )] (UMLS (CSP) C0021213) =Indicator, Reagent, or Diagnostic Aid ;
=Chemical;
=acid;
Alkylating Activity;
buffer;
chelating agent;
Contrast Agent;
culture media;
detergent;
dye;
molecular probe;
sulfhydryl reagent;
electron acceptor;
catalyst;
base;
reducing agent;
acylating agent;
calcium indicator;
radiolabel |
- 507. RBM5
- [This gene plays a role in the mediation of nucleic acid-binding interactions. ( NCI )] (UMLS (NCI) C1419301) RBM5 Gene;
RNA Binding Motif Protein 5 Gene =Gene or Genome | - 557. Real Time
- [Query response to occur in real time. ( HL7V3.0 )] (UMLS (HL7) C1550177) =Idea or Concept =Response modality;
ResponseModality |
- 508. RBM6
- [This gene plays a role in RNA recognition processes and has tumor suppressor activity. ( NCI )] (UMLS (NCI) C1335604) RBM6 Gene;
RNA Binding Motif Protein 6 Gene;
=Gene or Genome ;
| - 558. real time model
- [ ] (UMLS (CSP) C0872363) =Intellectual Product ;
|
- 509. RBX1
- [Widely expressed by human RBX1 Gene (RING-Box Family), conserved cytoplasmic and nuclear 108-aa 12.3-kDa RING Box Protein 1, containing a RING-type zinc finger, mediates protein turnover of cell cycle, signal transduction, and transcription proteins by ubiquitination and proteasomal degradation. A component of various SCF, SCF-like, and CBC multisubunit E3 ubiquitin ligase complexes, RBX1 may recruit E2 enzymes to the complex through its RING-type zinc finger and heterodimerizes with cullins in the third step of ubiquitin conjugation reactions to catalyze ubiquitin polymerization. RBX1 promotes neddylation of CUL1 and probably CUL2. It also probably interacts with CDC34 and may stimulate CDC34 autoubiquitination. (NCI) ( NCI )] (UMLS (NCI) C1313794) Regulator of Cullins 1;
RING Box Protein 1;
RING Finger Protein;
RING Finger Protein 75;
ROC1;
ZYP Protein =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 559. RealmOfUse
- [The jurisdiction or realm within which the domain will be used. A realm might be a country, a group of countries, a region of the world, or an organization. ( HL7V3.0 )] (UMLS (HL7) C1701906) =Spatial Concept ;
=VocabularyDomainQualifier;
=CA;
North America;
UNITED STATES;
Universal;
|
- 510. RBX1
- [This gene plays a critical role in ubiquitination. ( NCI )] (UMLS (NCI) C1335605) RBX1 Gene;
Ring-Box 1 Gene;
=Gene or Genome ;
| - 560. Reanastomosis of urethra
- [ ] (UMLS (ICD9CM) C0194643) =Therapeutic or Preventive Procedure
|
- 511. RC-160
- (UMLS (NCI) C0072994) =Amino Acid, Peptide, or Protein; Pharmacologic Substance
| - 561. REASON FOR CONSULT NOS
- [ ] (UMLS (ICD9CM) C0041880) =Finding ;
|
- 512. rCD4
- [A recombinant human soluble CD4 with antiviral activity. Recombinant human soluble CD4 has the amino terminus but not the T-cell binding domain of the endogenous CD4 antigen. This soluble CD4 protein competitively binds to envelope glycoprotein (gp120) of human immunodeficiency virus (HIV) resulting in inhibition of interaction between gp120 and the endogenous CD4 antigen, thereby blocking viral recognition of CD4 and subsequent entry of HIV into CD4 bearing cells. ( NCI )] (UMLS (NCI) C0279074) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
| - 562. ReasonForNotEvaluatingDevice
- [Code assigned to indicate the rationale for not performing an evaluation investigation on a device for which a defect has been reported. Examples include: device received in a condition that made analysis impossible, device evaluation anticipated but not yet begun, device not made by company. ( HL7V3.0 )] (UMLS (HL7) C1696161) =Intellectual Product =ActReason;
|
- 513. RCMD
- [A myelodysplastic syndrome characterized by bi-cytopenia or pancytopenia and dysplastic changes in 10% or more of the cells in two or more of the myeloid cell lines. A minority of cases progress to acute myeloid leukemia. (WHO, 2001) ( NCI )] (UMLS (NCI) C0796466) Refractory Cytopenia with Multilineage Dysplasia;
=Neoplastic Process | - 563. REATTACH AMPUTATED EAR
- [ ] (UMLS (ICD9CM) C0395659) =Therapeutic or Preventive Procedure
|
- 514. RCMD-RS
- [A myelodysplastic syndrome characterized by bi-cytopenia or pancytopenia, dysplastic changes in 10% or more of the cells in two or more of the myeloid cell lines, and 15% or more ringed sideroblasts in the bone marrow. (WHO, 2001) — 2003 ( NCI )] (UMLS (NCI) C1301356) Refractory Cytopenia with Multilineage Dysplasia and Ringed Sideroblasts =Neoplastic Process
| - 564. Reattachment of extremity
- [ ] (UMLS (ICD9CM) C0408884) =Therapeutic or Preventive Procedure
|
- 515. RCN2
- [This gene is involved in calcium-binding processes. ( NCI )] (UMLS (NCI) C1335606) RCN2 Gene;
Reticulocalbin 2, EF-Hand Calcium Binding Domain Gene;
=Gene or Genome ;
| - 565. Reattachment of tendon
- [ ] (UMLS (ICD9CM) C0185398) =Therapeutic or Preventive Procedure
|
- 516. RDA
- [PCR-based method for isolating unique sequences; also, used for comparing differences between two complex genomes. ( CSP )] (UMLS (NCI) C0597707) =Molecular Biology Research Technique ;
=PCR;
| - 566. Rebeccamycin Analogue, Tartrate Salt
- (UMLS (NCI) C1328676) =Organic Chemical; Pharmacologic Substance
|
- 517. RDE - Pharmacy/treatment refill authorization request
- (UMLS (HL7) C1549261) =Health Care Activity =Event Type;
| - 567. Rebetol
- (UMLS (NCI) C1170576) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance ;
|
- 518. RDE _ Pharmacy/treatment encoded order
- (UMLS (HL7) C1549247) =Health Care Activity =Event Type;
| - 568. Rebif
- (UMLS (NCI) C0752980) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
|
- 519. rDNA
- [DNA sequences encoding ribosomal RNA and the segments of DNA separating the individual ribosomal RNA genes, referred to as ribosomal spacer DNA. ( CSP )] (UMLS (CSP) C0012933) =Nucleic Acid, Nucleoside, or Nucleotide; Biologically Active Substance ;
=deoxyribonucleic acid;
| - 569. Rebreather Mask*
- (UMLS (HL7) C0694641) =Spatial Concept =drug administration route;
|
- 520. RDR
- (UMLS (HL7) C1549885) =Intellectual Product =Message structure;
| - 570. REC BIL FEM HERN W OBSTR
- [ ] (UMLS (ICD9CM) C0156132) =Disease or Syndrome; Anatomical Abnormality
|
- 521. RDR - Pharmacy/treatment dispense information
- (UMLS (HL7) C1549326) =Health Care Activity =Event Type;
| - 571. REC UNIL FEM HERN W GANG
- [ ] (UMLS (ICD9CM) C0156116) =Acquired Abnormality; Disease or Syndrome
|
- 522. RDS _ Pharmacy/treatment dispense
- (UMLS (HL7) C1549249) =Health Care Activity =Event Type;
| - 572. REC UNIL FEM HERN W OBST
- [ ] (UMLS (ICD9CM) C0156130) =Acquired Abnormality; Disease or Syndrome
|
- 523. RDY - Display response in response to QBP^Q15
- (UMLS (HL7) C1549214) =Health Care Activity =Event Type;
| - 573. recA protein
- [A family of recombinases initially identified in BACTERIA. They catalyze the ATP-driven exchange of DNA strands in GENETIC RECOMBINATION. The product of the reaction consists of a duplex and a displaced single-stranded loop, which has the shape of the letter D and is therefore called a D-loop structure. ( MSH )] (UMLS (CSP) C0034767) =Amino Acid, Peptide, or Protein; Enzyme ;
|
- 524. RE
- [An Southern Africa, occupying an island in the Indian Ocean, east of Madagascar. (NCI) ( NCI )] (UMLS (NCI) C0035373) =Geographic Area ;
| - 574. Recalcification
- [The addition of calcium back to a specimen after it was removed by chelating agents ( HL7V3.0 )] (UMLS (HL7) C1551379) =Intellectual Product =ActSpecimenTreatmentCode;
|
- 525. Re-186
- [A radioisotope with an atomic number of 75 and a half life of 90 hours that emits beta particles and gamma rays and is used in cancer treatment and diagnostic imaging technique. (NCI) ( NCI )] (UMLS (NCI) C0361302) =Indicator, Reagent, or Diagnostic Aid; Element, Ion, or Isotope ;
| - 575. Recalification
- (UMLS (HL7) C1550108) =Therapeutic or Preventive Procedure =Therapeutic Interventions;
|
- 526. Re-admission
- (UMLS (HL7) C1548168) =Idea or Concept =Re-Admission Indicator;
| - 576. Received into inventory (for specified patient)
- (UMLS (HL7) C1548989) =Idea or Concept =Blood Product Dispense Status;
|
- 527. Re-Admission Indicator
- (UMLS (HL7) C1550376) =Qualitative Concept =HL7 Vocabulary Version 2.5;
=Re-admission | - 577. Received signed
- (UMLS (HL7) C1553448) =Idea or Concept =LanguageAbilityMode;
|
- 528. RE-ENTRY OPERATION
- [ ] (UMLS (ICD9CM) C0190368) =Therapeutic or Preventive Procedure
| - 578. Received spoken
- (UMLS (HL7) C1551045) =Idea or Concept =LanguageAbilityMode;
|
- 529. Re-used MET
- [This message element type was previously defined in this HMD and is being reused ( HL7V3.0 )] (UMLS (HL7) C1554126) =Idea or Concept =MdfHmdMetSourceType;
| - 579. Received written
- (UMLS (HL7) C1551046) =Idea or Concept =LanguageAbilityMode;
|
- 530. Reaction
- [A response generated by a stimulus. ( NCI )] (UMLS (NCI) C0443286) =Functional Concept
| - 580. receiver
- [The person (or organization) who receives the product of an Act. ( HL7V3.0 )] (UMLS (HL7) C1551356) =Idea or Concept =indirect target;
◊ [The entity is the receiver of the transmission. ( HL7V3.0 )] (UMLS (HL7) C1553422) Idea or Concept CommunicationFunctionType; |
- 531. Reaction Alert
- [Proposed therapy may be inappropriate or contraindicated based on the potential for a patient reaction to the proposed product ( HL7V3.0 )] (UMLS (HL7) C1553540) =Intellectual Product =Observation Alert;
=Intolerance Alert;
Allergy Alert | - 581. Receiver responsibility
- [This property holds the identifier of the follow-on interaction, when the receiving application role for an interaction has the responsibility to initiate a follow-on interaction. ( HL7V3.0 )] (UMLS (HL7) C1554146) =Idea or Concept =HL7DefinedRoseProperty;
|
- 532. reaction rate
- [ ] (UMLS (CSP) C0678608) =Temporal Concept
| - 582. Recent
- [Near to or not long before the present. ( NCI )] (UMLS (NCI) C0332185) =Temporal Concept
|
- 533. reaction rate (chemical)
- [ ] (UMLS (CSP) C0598136) =Phenomenon or Process
| - 583. RECENT DETACHMENT, TOTAL
- [ ] (UMLS (ICD9CM) C0154813) =Disease or Syndrome ;
|
- 534. Reaction to Bacterial Contamination
- (UMLS (HL7) C1549010) =Pathologic Function =Transfusion Adverse Reaction;
| - 584. Receptor
- [A molecule inside or on the surface of a cell that binds to a specific substance and causes a specific physiologic effect in the cell. ( NCI )] (UMLS (NCI) C0597357) =Amino Acid, Peptide, or Protein; Receptor =binding protein;
=hormone receptor;
drug receptor;
Cell Surface Receptor;
antibody receptor;
leukocyte adhesion molecule;
Cytoplasmic Receptor;
carbohydrate receptor;
nonvisual photoreceptor;
vitamin receptor |
- 535. ReactionActionTaken
- [Code used to indicate the action taken by practitioner in response to the problem (whether drug or device related) that is reported in the ICSR. Examples include: failing device replaced, medication stopped, medication dose adjusted. ( HL7V3.0 )] (UMLS (HL7) C1696160) =Clinical Attribute =Individual Case Safety Report Value Domains;
| - 585. Receptor (TNFRSF)-Interacting Serine-Threonine Kinase 1 Gene
- [This gene plays a role in apoptosis and signal transduction. ( NCI )] (UMLS (NCI) C1335623) RIPK1;
RIPK1 Gene =Gene or Genome ;
|
- 536. Reactivate deactivated record
- (UMLS (HL7) C1549605) =Intellectual Product =Record-level event code;
| - 586. receptor activation
- [Receptor Activation typically involves a high-affinity binding interaction of a signaling molecule (ligand) with a specific target protein causing a conformational and functional change in the receptor molecule. Altered interaction of the ligand-bound receptor with target molecules leads in turn to changes in cellular physiology through modification of the activity of one or more signal transduction pathways. ( NCI )] (UMLS (CSP) C1514758) =Cell Function
|
- 537. REACTIVE CONFUSION
- (UMLS (ICD9CM) C0152124) =Mental or Behavioral Dysfunction ;
| - 587. receptor binding
- [Receptor Binding involves a temporary non-covalent, typically highly specific and high affinity, interaction through intermolecular physical forces of attraction and spatial complementarity with a diverse group of intrinsic membrane or cytoplasmic proteins that mediate the biological effects of secreted regulatory signaling molecules through modification of the activity of signal transduction pathways. ( NCI )] (UMLS (CSP) C0597358) =Molecular Function ;
=protein binding;
|
- 538. Reactive Cutaneous Fibrous Lesion
- (UMLS (NCI) C1335666) =Disease or Syndrome ;
| - 588. receptor coupling
- [process by which ligand-receptor complex, usually extracellular, effects intracellular events; e.g., via enzyme activity of intracellular domain of receptor protein, or via G protein interactions with other membrane proteins such as ion channels or adenylate cyclase. ( CSP )] (UMLS (CSP) C0597359) =Molecular Function ;
=Signal Transduction;
|
- 539. reactive depression
- [Depression precipitated by events in a person's life. ( NCI )] (UMLS (CSP) C0011579) =Mental or Behavioral Dysfunction
| - 589. receptor density
- [ ] (UMLS (CSP) C0599283) =Genetic Function
|
- 540. reactive hyperemia
- [excess of blood in a body part following restoration of its temporarily arrested flow. ( CSP )] (UMLS (CSP) C0178824) =Pathologic Function ;
=blood circulation;
| - 590. Receptor Down Regulation
- [Due to internalization of ligand-receptor complexes, increased receptor turnover, or decreased receptor expression following exposure to a ligand or agent, Receptor Down Regulation involves a decrease in the number of ligand-specific cellular proteins that bind to, and mediate, the effects of a regulatory molecule. ( NCI )] (UMLS (NCI) C0949469) receptor downregulation =Molecular Function ;
|
- 541. Reactive Lymphocytosis
- (UMLS (NCI) C1335667) =Disease or Syndrome ;
| - 591. receptor expression
- [process by which functional receptors appear, migrate, and disappear at the cell surface; involves gene expression, protein biosynthesis, posttranslational modification, membrane transport, and degradation; can be used to index interspecies receptor gene implants. ( CSP )] (UMLS (CSP) C0597360) =Genetic Function ;
=Expressed;
|
- 542. reactive oxygen intermediate
- [ ] (UMLS (CSP) C0920643) =Biologically Active Substance ;
| - 592. receptor function
- [ ] (UMLS (CSP) C0920644) =Molecular Function ;
|
- 543. reactive psychotic depression
- [ ] (UMLS (CSP) C0011580) =Mental or Behavioral Dysfunction
| - 593. Receptor Gene
- [Receptor Genes encode cell surface or cytoplasmic receptor proteins that each bind to specific signaling factors (such as a hormone, antigen, or neurotransmitter) causing a conformational and functional change in the ligand-bound receptor, altering its interaction with target molecules and leading to changes in cellular physiology through modification of the activity of one or more signal transduction pathways. ( NCI )] (UMLS (NCI) C1335671) =Gene or Genome ;
|
- 544. reactive site (enzyme)
- [ ] (UMLS (CSP) C0597752) =Functional Concept ;
| - 594. receptor internalization
- [The process by which cell surface receptors are monoubiquitinated following ligand-induced activation, and subsequently taken up into endocytic vesicles and targeted to the lysosome or vacuole for degradation; serves as a mechanism to downregulate receptor signaling. [GOC:mah, PMID:15006537] ( GO )] (UMLS (CSP) C0599281) =Phenomenon or Process
|
- 545. Read
- [to examine and attempt to comprehend the meaning of written or printed characters, words, or sentences; includes reading Braille. ( CSP )] (UMLS (NCI) C0034754) =Daily or Recreational Activity =communication behavior;
Language Ability | - 595. receptor mediated endocytosis
- [pathway for taking up substances which first bind to specific cell surface receptors in coated pits and are then internalized by endocytosis; also internalizes obsolete cell surface receptors. ( CSP )] (UMLS (CSP) C0597361) =Cell Function ;
=endocytosis;
=dephosphin |
- 546. Read Classification
- [The Read Clinical Classification of Medicine, Park View Surgery, 26 Leicester Rd., Loughborough LE11 2AG (includes drug procedure and other codes, as well as diagnostic codes). ( HL7V3.0 )] (UMLS (HL7) C1547163) =Intellectual Product =Code;
CodeSystem | - 596. Receptor Protein-Tyrosine Kinase
- [A class of membrane receptors that contain protein tyrosine kinase activity. This enzymatic activity is integral to the function of the receptor as a signal transducer; the phosphorylation event alters the functional activity of its protein substrate. ( NCI )] (UMLS (NCI) C0206364) =Amino Acid, Peptide, or Protein; Enzyme; Receptor
|
- 547. reading disorder diagnosis
- [ ] (UMLS (CSP) C0872258) =Diagnostic Procedure ;
| - 597. receptor recycling
- [The process by which receptor molecules are returned to an active state and in an active cellular location after they have been stimulated by a ligand. An active state is when the receptor is ready to receive a signal. [GOC:dph] ( GO )] (UMLS (CSP) C0599282) =Cell Function
|
- 548. Readministration
- [The repeated act of the dispensing, applying, or tendering of something to another after an initial treatment. ( NCI )] (UMLS (NCI) C0376495) =Therapeutic or Preventive Procedure
| - 598. receptor sensitivity
- [parameter which is increased by agonists and decreased by antagonists, usually measured as the effective dose of ligand for binding or physiological endpoint. ( CSP )] (UMLS (CSP) C0597362) =Functional Concept ;
=Pharmacologic;
|
- 549. Reagan Lowe Medium
- (UMLS (HL7) C1550085) =Biomedical or Dental Material ;
=Additive/Preservative;
| - 599. Receptor Serine/Threonine Kinase
- [Encoded by Receptor Serine/Threonine Kinase Genes, Receptor Serine/Threonine Kinases bind to specific signaling factors causing a conformational and functional change in the ligand-bound receptor, altering its interaction with target molecules, increasing the receptor kinase activity, and leading to changes in cellular physiology through modification of the activity of one or more signal transduction pathways. ( NCI )] (UMLS (NCI) C0219806) =Amino Acid, Peptide, or Protein; Enzyme; Receptor
|
- 550. Reagan Lowe Medium
- [A transport medium formulated to maintain Bordetella pertussis viability. ( HL7V3.0 )] (UMLS (HL7) C1561486) =Intellectual Product =MaterialEntityAdditive;
| - 600. Receptor Serine/Threonine Kinase Gene
- [Receptor Serine/Threonine Kinase Genes encode receptor proteins that each bind to specific signaling factors causing a conformational and functional change in the ligand-bound receptor, altering its interaction with target molecules, increasing the receptor kinase activity, and leading to changes in cellular physiology through modification of the activity of one or more signal transduction pathways. ( NCI )] (UMLS (NCI) C1335672) =Gene or Genome ;
|
home
